Background The use of music interventions as a non-pharmacological therapy to improve
cognitive and behavioral symptoms in Alzheimer's disease (AD) patients has gained …

The strategies involved in the development of therapeutics for neurodegenerative disorders
are very complex and challenging due to the existence of the blood-brain barrier (BBB), a …

Growing evidence suggests that fine particulate matter (PM2. 5) likely increases the risks of
dementia, yet little is known about the relative contributions of different constituents. Here …

Delphi is a scientific method to organize and structure an expert discussion aiming to
generate insights on controversial topics with limited information. The technique has seen a …

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its …

The risk of Alzheimer disease (AD) increases with age, family history and informative genetic
variants. Sadly, there is still no cure or means of prevention. As in other complex diseases …

Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide.
Although type 2 diabetes is associated with an increased risk of dementia, awareness of the …

Hypertension affects two-thirds of people aged> 60 years and significantly increases the risk
of both vascular cognitive impairment and Alzheimer's disease. Hypertension compromises …

Background The number of individuals living with dementia is increasing, negatively
affecting families, communities, and health-care systems around the world. A successful …

As life expectancy continues to increase worldwide, age-related dysfunction will largely
impact our societies in the future. Aging is well established to promote the deterioration of …